Objective: We aimed to measure separately the contributions of heat and humidity to changes in levels of 34 markers of inborn disorders in dried-blood-spot (DBS) samples. Design and methods: We stored paired sets of DBSs at 37. °C for predetermined intervals in low-humidity and high-humidity environments. Marker levels of all samples in each complete sample set were measured in a single analytic run. Results: During the 30 ± 5. day studies, galactose-1-phosphate uridyltransferase and biotinidase lost almost 65% of initial activities in low-humidity storage; most of the degradation in 27 other markers was attributable to adverse effects of high-humidity storage; seven markers in DBSs stored at high humidity lost more than 90% of initial levels by the end of the study and 4 of the 7 lost more than 50% of initial levels within the first week of storage. Conclusions: Minimizing both humidity and temperature in DBS transportation and storage environments is essential to maintaining sample integrity. © 2011 The Canadian Society of Clinical Chemists.
CITATION STYLE
Adam, B. W., Hall, E. M., Sternberg, M., Lim, T. H., Flores, S. R., O’Brien, S., … Hannon, W. H. (2011). The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States. Clinical Biochemistry, 44(17–18), 1445–1450. https://doi.org/10.1016/j.clinbiochem.2011.09.010
Mendeley helps you to discover research relevant for your work.